Atosiban Impurity E is a related peptide variant that forms during atosiban synthesis or storage. Structural deviations adjust disulfide geometry, hydrophobic packing, and chromatographic behavior. Researchers employ it as a reference to refine impurity profiles and degradation mapping. Applications include analytical-method validation, process understanding, and structural-variant characterization.
CAT No: Z10-101-220
Synonyms/Alias:Atosiban impurity E,Mpr-DTyr(Et)-Ile-Thr-Asn-Cys-Pro-Cyclo(Orn)(Mpr1&Cys6 bridge);
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More